Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25726150 | 1.00 | KDM4E (0.40) | KDM4EALDH1A1RECQLGAAMEN1 | |
| SCHEMBL16419857 | 1.00 | KDM4E (0.40) | KDM4EALDH1A1RECQLGAAMEN1 | |
| SCHEMBL20234316 | 1.00 | KDM4E (0.40) | KDM4EALDH1A1RECQLGAAMEN1 | |
| SCHEMBL21042699 | 1.00 | KDM4E (0.40) | KDM4EALDH1A1RECQLGAAMEN1 | |
| SCHEMBL25733637 | 0.92 | EPHX2 (0.36) | KDM4EALDH1A1RECQLGAAMEN1 | |
| SCHEMBL9540608 | 0.90 | KDM4E (0.45) | KDM4EALDH1A1GAAMEN1KMT2A | |
| SCHEMBL14198320 | 0.90 | KDM4E (0.45) | KDM4EALDH1A1GAAMEN1KMT2A | |
| SCHEMBL9541679 | 0.90 | KDM4E (0.45) | KDM4EALDH1A1GAAMEN1KMT2A | |
| SCHEMBL18551592 | 0.89 | KDM4E (0.37) | KDM4EALDH1A1RECQLGAAMEN1 | |
| SCHEMBL21042707 | 0.88 | KDM4E (0.38) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110650785-B | Absorbent and process for selective removal of hydrogen sulfide | 巴斯夫欧洲公司 | 2022-05-24 | — | — | CN | claimed |
| US-11241652-B2 | Absorbent and process for selectively removing hydrogen sulfide | BASF SE (REITSTÖTTER, KINZEBACH & PARTNER) (DE) | 2022-02-08 | — | — | US | claimed |
| EP-3624922-B1 | ABSORBENT, PROCESS FOR PRODUCING IT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE USING IT | BASF SE (DE) | 2021-07-07 | — | — | EP | claimed |
| US-20200164303-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2020-05-28 | — | — | US | claimed |
| EP-3624922-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2020-03-25 | — | — | EP | claimed |
| CN-110650785-A | Absorbent and process for selective removal of hydrogen sulfide | 巴斯夫欧洲公司 | 2020-01-03 | — | — | CN | claimed |
| WO-2018210738-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2018-11-22 | — | — | WO | claimed |
| EP-4549621-A1 | PROCESS FOR MAKING AMINES FROM ALCOHOLS USING HYDROGEN HAVING LOW DEUTERIUM CONTENT PRODUCED WITH NON-FOSSIL ENERGY | BASF SE (DE) | 2025-05-07 | — | — | EP | disclosed |
| EP-4549618-A1 | PROCESS FOR MAKING AMINES FROM NITRILE COMPOUNDS USING HYDROGEN HAVING LOW DEUTERIUM CONTENT PRODUCED WITH NON-FOSSIL ENERGY | BASF SE (DE) | 2025-05-07 | — | — | EP | disclosed |
| EP-4549616-A1 | PROCESS FOR MAKING AMINES FROM CARBONYL COMPOUNDS USING HYDROGEN HAVING LOW DEUTERIUM CONTENT PRODUCED WITH NON-FOSSIL ENERGY | BASF SE (DE) | 2025-05-07 | — | — | EP | disclosed |
| EP-4549620-A1 | PROCESS FOR MAKING AMINES FROM NITRILE COMPOUNDS USING HYDROGEN HAVING LOW DEUTERIUM CONTENT PRODUCED WITH NON-FOSSIL ENERGY IN THE ABSENCE OF AMMONIA | BASF SE (DE) | 2025-05-07 | — | — | EP | disclosed |
| US-11813334-B2 | Polyethylene glycol conjugate drug, and preparation method therefor and use thereof | Chongqing Upgra Biotechnology Co., Ltd. (CN) | 2023-11-14 | — | — | US | disclosed |
| US-20230348671-A1 | POLYETHYLENE GLYCOL CONJUGATE DRUG SYNERGIST, AND PREPARATION METHOD THEREFOR, AND USE THEREOF | Chongqing Upgra Biotechnology Co., Ltd. (CN) | 2023-11-02 | — | — | US | disclosed |
| WO-2018210738-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE (DE) | 2018-11-22 | — | — | WO | disclosed |
| US-9957290-B2 | Derivatives of amphotericin B | SFUNGA THERAPEUTICS, INC. (US) | 2018-05-01 | — | — | US | disclosed |
| US-8486183-B2 | Alkylamino alkyloxy (alcohol) monoalkyl ether for acid gas scrubbing process | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-07-16 | — | — | US | disclosed |
| US-20120085978-A1 | SURFACE-MODIFIED METAL OXIDE POWDER AND PROCESS FOR PRODUCING SAME | NIPPON AEROSIL CO., LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-20110202328-A1 | System for the determination of selective absorbent molecules through predictive correlations | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2011-08-18 | — | — | US | disclosed |
| US-20110202328-A1 | System for the determination of selective absorbent molecules through predictive correlations | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2011-08-18 | — | — | US | disclosed |
| US-20100037775-A1 | ALKYLAMINO ALKYLOXY (ALCOHOL) MONOALKYL ETHER FOR ACID GAS SCRUBBING PROCESS | EXXON-MOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100037775-A1 | ALKYLAMINO ALKYLOXY (ALCOHOL) MONOALKYL ETHER FOR ACID GAS SCRUBBING PROCESS | ALKBH3, ALKBH1, ALKBH2 | KDM4E 721/4885ALDH1A1 276/4885RECQL 4879/4885 |
| US-20230348671-A1 | POLYETHYLENE GLYCOL CONJUGATE DRUG SYNERGIST, AND PREPARATION METHOD THEREFOR, AND USE THEREOF | THEM6, WEE1, SLC10A1 | KDM4E 3313/4885ALDH1A1 1677/4885RECQL 4596/4885 |
| US-20200164303-A1 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | C1S, C5, C1R | KDM4E 1368/4885ALDH1A1 661/4885RECQL 358/4885 |
| US-11241652-B2 | Absorbent and process for selectively removing hydrogen sulfide | C1S, C5, C1R | KDM4E 1368/4885ALDH1A1 661/4885RECQL 358/4885 |
| US-11813334-B2 | Polyethylene glycol conjugate drug, and preparation method therefor and use thereof | FAR1, SLC10A1, THEM6 | KDM4E 3520/4885ALDH1A1 1105/4885RECQL 3757/4885 |
| US-20120085978-A1 | SURFACE-MODIFIED METAL OXIDE POWDER AND PROCESS FOR PRODUCING SAME | TFRC, ITGA4, FEM1B | KDM4E 1807/4885ALDH1A1 4664/4885RECQL 3953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.